Distribution of Candida species causing bloodstream infections  by Lai, Chih-Cheng et al.
Journal of Microbiology, Immunology and Infection (2012) 45, 161e162Available online at www.sciencedirect.com
journal homepage: www.e- jmii .comLETTER TO THE EDITOR
Distribution of Candida species causing bloodstream
infectionsSir,
Recently, Chi et al1 compared the risk factors and outcomes
of bloodstream infections due to Candida albicans with
those due to non-albicans species at a hospital in northern
Taiwan in the August 2011 issue of the Journal of Microbi-
ology, Immunology, and Infection. In that study, the
authors retrospectively enrolled 108 patients with candi-
demia during the period October 2007 to July 2009. Of
those patients, 61 (56.5%) had C. albicans bloodstream
infections and 47 (43.5%) had non-albicans candidemia. The
species distributions were as follows: C. glabrata (n Z 19,
17.6%), C. tropicalis (nZ 14, 13.0%), C. krusei (nZ 1, 1%),
and C. haemonulonii (n Z 1, 1%). Although these findings
are interesting, we wondered whether they could be
generalized to other parts of Taiwan. Therefore, we per-
formed this study to investigate the species distribution of
Candida isolates causing fungemia in southern Taiwan.
This retrospective study was conducted at the Liouying
branch of the Chi Mei Medical Center, a 900-bed hospital in
southern Taiwan. All blood cultures positive for Candida
species during the period January 2005 to December 2010
were identified in the database of the Microbiology Labo-
ratory of the hospital. Each patient was included only once
at the time of detection of the first bloodstream infection.
The identifications of Candida species were confirmed using
the API 20C and Vitek YBC systems (bioMerieux Vitek, St.
Louis, MO, USA).
During the study period, a total of 935 blood culture
specimens from 407 patients were positive for Candida
species. The most prevalent species were C. albicans
(nZ 245, 60.0%), followed by C. tropicalis (nZ 79, 19.4%),
C. parapsilosis (n Z 61, 15.0%), C. glabrata (n Z 45,
11.0%), C. guilliermondii (n Z 14, 3.4%), C. sake (n Z 1,
0.2%), C. famata (n Z 1, 0.2%), and C. pelliculosa (n Z 1,
0.2%). Candida species could not be determined in three
(0.7%) of the patients. In addition, 36 (8.8%) patients had
polymicrobial candidemia with two different Candida
species. Interestingly, we first identified a case of1684-1182/$36 Copyright ª 2012, Taiwan Society of Microbiology. Publ
doi:10.1016/j.jmii.2012.01.005C. pelliculosa candidemia that developed in a 72-year-old
female patient, who had undergone an operation for
duodenal perforation. As part of her treatment, a central
venous catheter had been placed for the administration of
total parenteral nutrition. Although she responded well to
fluconazole and removal of the catheter, she died due to
nosocomial infection with multiple organ failure.
There were two significant findings in this study. First,
C. albicans was the most prevalent Candida species causing
fungemia in southern Taiwan, a finding consistent with
that in northern Taiwan and in other countries.1e7 The
species distribution of other Candida species, however,
varied in northern and southern Taiwan, a finding that is
also consistent with reports from other countries. 1e7
For example, in Spain, a nationwide study of 984 episodes
of candidemia showed that C. parapsilosis (20.7%) was
the second most common Candida isolate, followed by
C. glabrata (13.6%), C. tropicalis (10.8%), and C. krusei
(2.1%).2 In a study of 107 episodes of candidemia in the UK,
C. albicans was the most common species, accounting for
43% of the episodes, followed by C. glabrata (31%) and C.
parapsilosis (20%).3 However, several studies, including the
present work in southern Taiwan, disclosed that the second
most common Candida species was C. tropicalis.4e7 Second,
our study is the first to report a case of catheter-related
bloodstream infection caused by C. pelliculosa in Taiwan.
In conclusion, C. albicans is the most important species
associated with candidemia. The distribution of non-albi-
cans Candida species causing fungemia varies from hospital
to hospital and from country to country.
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